Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.790
-0.140 (-2.84%)
At close: May 26, 2026, 4:00 PM EDT
4.800
+0.010 (0.21%)
After-hours: May 26, 2026, 4:20 PM EDT
Lifecore Biomedical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Lifecore Biomedical stock has a consensus rating of "Buy" and an average price target of $6.67. The average 1-year stock price forecast is 39.25% higher than the current stock price, while the lowest is $5.00 (+4.38%) and the highest is $9.00 (+87.89%).
Price Target: $6.67 (+39.25%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Buy Maintains $6 | Buy | Maintains | $6 | +25.26% | May 7, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 6, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $9 | Buy | Maintains | $9 | +87.89% | May 6, 2026 |
| Stephens | Stephens | Hold Reiterates $8.5 → $5 | Hold | Reiterates | $8.5 → $5 | +4.38% | Mar 17, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Dec 29, 2025 |
Financial Forecast
Revenue This Year
124.62M
from 129.46M
Decreased by -3.74%
Revenue Next Year
132.84M
from 124.62M
Increased by 6.60%
EPS This Year
-1.01
from -0.93
EPS Next Year
-0.97
from -1.01
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 129.5M | 147.3M | ||||||
| Avg | 124.6M | 132.8M | ||||||
| Low | 117.6M | 122.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 0.0% | 18.2% | ||||||
| Avg | -3.7% | 6.6% | ||||||
| Low | -9.2% | -1.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.85 | -0.85 | |
| Avg | -1.01 | -0.97 | |
| Low | -1.20 | -1.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.